|
|
 |
|
|
|
Components
| 10X Genomics, Inc. (Class A) |
TXG |
| AbbVie Inc. |
ABBV |
| ACADIA Pharmaceuticals Inc. |
ACAD |
| Alkermes Plc |
ALKS |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
| Amgen Inc. |
AMGN |
| Amneal Pharmaceuticals, Inc. |
AMRX |
| Arcus Biosciences, Inc. |
RCUS |
| Arcutis Biotherapeutics, Inc. |
ARQT |
| Arrowhead Pharmaceuticals, Inc. |
ARWR |
| Biogen Inc. |
BIIB |
| BioMarin Pharmaceutical Inc. |
BMRN |
| Bristol-Myers Squibb Company |
BMY |
| Cardinal Health, Inc. |
CAH |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
| Charles River Laboratories International, Inc. |
CRL |
| Elanco Animal Health Incorporated |
ELAN |
| Eli Lilly and Company |
LLY |
| Exelixis, Inc. |
EXEL |
| Gilead Sciences, Inc. |
GILD |
| Guardant Health, Inc. |
GH |
| Halozyme Therapeutics, Inc. |
HALO |
| Illumina, Inc. |
ILMN |
| Incyte Corporation |
INCY |
| Ionis Pharmaceuticals, Inc. |
IONS |
| Jazz Pharmaceuticals Plc |
JAZZ |
| Johnson & Johnson |
JNJ |
| Krystal Biotech, Inc. |
KRYS |
| Kymera Therapeutics, Inc. |
KYMR |
| Ligand Pharmaceuticals Inc. (Class B) |
LGND |
| Medpace Holdings, Inc. |
MEDP |
| Merck & Co., Inc. |
MRK |
| Mirum Pharmaceuticals, Inc. |
MIRM |
| Moderna, Inc. |
MRNA |
| Neurocrine Biosciences, Inc. |
NBIX |
| Pfizer Inc. |
PFE |
| Protagonist Therapeutics, Inc. |
PTGX |
| PTC Therapeutics, Inc. |
PTCT |
| Regeneron Pharmaceuticals, Inc. |
REGN |
| Roivant Sciences Ltd. |
ROIV |
| Spyre Therapeutics, Inc. |
SYRE |
| Supernus Pharmaceuticals, Inc. |
SUPN |
| Tarsus Pharmaceuticals, Inc. |
TARS |
| TG Therapeutics, Inc. |
TGTX |
| Travere Therapeutics, Inc. |
TVTX |
| Twist Bioscience Corporation |
TWST |
| United Therapeutics Corporation |
UTHR |
| Vertex Pharmaceuticals Incorporated |
VRTX |
| Viatris Inc. |
VTRS |
| Zoetis Inc. |
ZTS |
|
|
|
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|